NCT00004940已完成3 期
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
OBJECTIVES:
I. Determine the long-term efficacy and safety of L-cysteine in the prevention photosensitivity in patients with erythropoietic protoporphyria.
详细描述
PROTOCOL OUTLINE: This is a phase III study, lasting 3 years; 1996-1999. Patients are administered L-cysteine orally twice daily, 2 capsules with breakfast and 2 with lunch.
Patients fill in questionnaires and diary sheets about their reaction to sunlight exposure, and have blood tested 3 times a year.
Completion date provided represents the completion date of the grant per OOPD records
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Study of Cysteine Hydrochloride for Erythropoietic ProtoporphyriaErythropoietic ProtoporphyriaNCT00004831FDA Office of Orphan Products Development20
已完成
不适用
The Efficacy of L-cysteine in Prevention of Cluster HeadacheCluster HeadacheNCT02310828Biohit Oyj60
已完成
不适用
The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine PatientsMigraineNCT02315833Biohit Oyj200
已完成
3 期
Effects of N-acetylcysteine on Diabetic Foot OxygenationFoot Ulcer, DiabeticNCT01082445University of Turin, Italy100
已完成
不适用
Acetyle-Cysteine in the treatment of obsessive-compulsive disorderObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201405271556N60Tehran University of Medical Sciences50